Jason H. Gill
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Biomedical Engineering
- Biomaterials top 5%
- Co-authors
- Jill M. SeargentJonathan P. LayePaul M. LoadmanSteven D. ShnyderMichael C. BibbyRuth RobertsJennifer M. AtkinsonIduna Fichtner
- Topics
- Peptidase Inhibition and Analysis (8 papers)Protease and Inhibitor Mechanisms (7 papers)Peroxisome Proliferator-Activated Receptors (5 papers)
- Cited by
- Cancer ResearchOncologyBiomaterials
- Journals
- SHILAP Revista de lepidopterologíaThe Journal of ImmunologyCancer Research
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Jason H. Gill
54 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 123
- Molecular Biology 961
- Oncology 472
- Cancer Research 460
- Biomedical Engineering 235
- Biomaterials 223
Countries citing papers authored by Jason H. Gill
This map shows the geographic impact of Jason H. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason H. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason H. Gill more than expected).
Fields of papers citing papers by Jason H. Gill
This network shows the impact of papers produced by Jason H. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason H. Gill. The network helps show where Jason H. Gill may publish in the future.
Co-authorship network of co-authors of Jason H. Gill
This figure shows the co-authorship network connecting the top 25 collaborators of Jason H. Gill. A scholar is included among the top collaborators of Jason H. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason H. Gill. Jason H. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | 7 | |
| 3 | 11 | |
| 4 | 8 | |
| 5 | 5 | |
| 6 | 7 | |
| 7 | 16 | |
| 8 | 7 | |
| 9 | Integration of pharmacogenetic principles as a core thread in the undergraduate pharmacy curriculum. | 1 |
| 10 | 36 | |
| 11 | 48 | |
| 12 | 34 | |
| 13 | 57 | |
| 14 | 23 | |
| 15 | Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development. | 80 |
| 16 | 111 | |
| 17 | 23 | |
| 18 | 34 | |
| 19 | 88 | |
| 20 | 30 |
About Jason H. Gill
Jason H. Gill is a scholar working on Cancer Research, Oncology and Pharmacology, having authored 56 papers that have together received 1.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Protease and Inhibitor Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). The work is most often cited by research in Cancer Research (460 citations), Oncology (472 citations) and Biomaterials (223 citations). Jason H. Gill has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Jill M. Seargent, Jonathan P. Laye, Paul M. Loadman, Steven D. Shnyder, Michael C. Bibby, Ruth Roberts, Jennifer M. Atkinson, Iduna Fichtner, Neil H. James and Eric B. Wheeldon. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.